Target intelligence / Profile preview

STAG1 divergent transcript (STAG1-DT)

Target: STAG1-DT
Molecular classification: Other (likely long non-coding RNA or uncharacterized transcript variant; not a protein, receptor, enzyme, ion channel, transporter, or transcription factor)

Overview

STAG1 divergent transcript (STAG1-DT) is annotated as a transcript adjacent to or sharing regulatory elements with the STAG1 gene, a key component of the cohesin complex. The cohesin complex plays essential roles in sister chromatid cohesion, DNA replication, and 3D genome regulation. While multiple protein-coding and non-coding STAG1 variants exist in stem cells and other tissues, the specific biological role, molecular classification, disease association, and druggability of STAG1-DT remain uncharacterized in the literature; research and annotation currently focus on STAG1 and its variants, not the divergent transcript. There is no recognized molecular or clinical utility linked to STAG1-DT as a therapeutic target, biomarker, or safety concern at present.

Other names: STAG1 divergent transcriptSTAG1-DT

Mechanism of action

None (no mechanisms defined for drugs targeting STAG1-DT)

Biological functions

Unknown (no clear biological function for STAG1-DT identified; recognized functions apply to STAG1 protein, not the divergent transcript)

Disease associations

Unknown (no disease roles attributed specifically to STAG1-DT; STAG1 protein is implicated in cancer and intellectual disability but not STAG1-DT itself)

Safety considerations

None (no safety concerns described for STAG1-DT)

Interacting drugs

None (no drugs described as interacting with STAG1-DT)

Biomarkers

None (not identified as a biomarker in any currently available literature)

Beyond the preview

Go deeper on STAG1 divergent transcript (STAG1-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on STAG1 divergent transcript (STAG1-DT).

Explore the full profile